MedPath

Comparison of drug efficacy between linaclotide and lubiprostone in constipation-predominant irritable bowel syndrome patients

Not Applicable
Conditions
constipation-predominant irritable bowel syndrome
Registration Number
JPRN-UMIN000028709
Lead Sponsor
Kawasaki Medical School
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

systemic inflammatory disease, malignancy disease, history of abdominal surgery

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath